Study on Sapropterin Dihydrochloride Oral Suspension in Healthy Subjects
NCT06481709
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Bioavailability
Interventions
DRUG:
RLF-OD032
DRUG:
Kuvan
Sponsor
APR Applied Pharma Research s.a.